Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty

Journal of Vascular Surgery

Volumn 42, Issue 2, 2005, Pages 252-258

  Cassar, Kevin ^a,b   Bachoo, Paul ^b   Ford, Isobel ^a   Greaves, Mike ^a   Brittenden, Julie ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN III; CLOPIDOGREL; D DIMER; HEPARIN; PLACEBO; THROMBIN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN CONTENT; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTITHROMBIN III; ASPIRIN; DOUBLE-BLIND METHOD; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 23744488545     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2005.04.027     Document Type: Article

References (23)

1. T. Herren, H. Stricker, A. Haeberli, D.D. Do, P.W. Straub Fibrin formation and degradation in patients with arteriosclerotic disease Circulation 90 1994 2679 2686
2. A. Strano, D. Hoppensteadt, J.M. Walenga, J. Fareed, C. Sabba, E. Berardi Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease Semin Thromb Hemost 22 Suppl 1 1996 35 40
3. J.G. van der Bom, M.L. Bots, F. Haverkate, P. Meijer, A. Hofman, C. Kluft, D.E. Grobbee Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease Thromb Haemost 85 2001 234 239
4. Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease Thromb Res 82 1996 523 532
5. A. Trifiletti, N. Barbera, M.A. Pizzoleo, S. Lucifora, S. Soraci, R. Scamardi Hemostatic disorders associated with arterial hypertension and peripheral arterial disease J Cardiovasc Surg 36 1995 483 485
6. K. Cassar, P. Bachoo, I. Ford, M. Greaves, J. Brittenden Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease Eur J Vasc Endovasc Surg 29 2005 171 176
7. M.H. Criqui, A. Fronek, E. Barrett-Connor, M.R. Klauber, S. Gabriel, D. Goodman The prevalence of arterial disease in a defined population Circulation 71 1985 510 515
8. J. Dormandy, L. Heeck, S. Vig The natural history of claudication risk to life and limb Semin Vasc Surg 12 1999 123 127
9. G.C. Leng, A.J. Lee, F.G. Fowkes, M. Whiteman, J. Dunbar, E. Housley Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population Int J Epidemiol 24 1996 1172 1181
10. K.G. Lehmann, E. Gonzales, B.D. Tri, N.D. Vaziri Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty basal state and effect of successful dilatation Am Heart J 137 1999 274 283
11. S. Peltonen, R. Lassila, J. Heikkila Activation of coagulation and fibrinolysis despite heparinisation during successful elective coronary angioplasty Thromb Res 82 1996 459 468
12. S. Suzuki, T. Matsuo, H. Kobayashi, M. Matsuo, C. Shimamo, M. Koide Antithrombotic treatment (argatroban vs heparin) in coronary angioplasty in angina pectoris effects on inflammatory, hemostatic, and endothelium-derived parameters Thromb Res 98 2000 269 279
13. M. Tschopl, D.A. Tsakiris, G.A. Marbet, K.H. Labs, K. Jager Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty Arterioscler Thromb Vasc Biol 17 1997 3208 3214
14. S. Yusufl, F. Zhaol, S.R. Mehtal, S. Chrolaviciusl, G. Tognonil, K.K. Foxl Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
15. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, M.K. Natarajan Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
16. C. Leon, A. Meike, A. Klocke, E. Morgenstern, C. Moosbauer, A. Eckly Platelet ADP receptors contribute to the initiation of intravascular coagulation Blood 103 2004 594 600
17. P. Savi, A. Bernat, A. Dumas, L. Ait-Chek, J.M. Herbert Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells Thromb Res 73 1994 117 124
18. T. Taka, E. Okano, J. Seki, J. Yamamoto Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress Haemostasis 29 1999 189 196
19. J.P. Herault, F. Dol, C. Gaich, A. Bernat, J.M. Herbert Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat Thromb Haemost 81 1999 957 960
20. K. Cassar, P. Bachoo, I. Ford, M. Greaves, J. Brittenden Double-blind randomised controlled trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin after lower limb angioplasty Br J Surg 92 2005 159 165
21. I. Muller, S. Massberg, W. Zierhut, C. 0Binz, A. Schuster, S. Rudiger-von Hoch Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB) Pathophysiol Haemost Thromb 32 2002 16 24
22. J.W. Eikelboom, J.I. Weitz, A. Budaj, F. Zhao, I. Copland, Maciejewski P for the CURE study investigators Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes Eur Heart J 23 2002 1771 1779
23. A. Weltermann, P. Fritsch, P.A. Kyrle, V. Schoenauer, G. Heinze, J. Wojta Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting Thrombo Res 112 2003 19 24